{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:45:55Z","timestamp":1793839555089,"version":"4.6.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["A3-S-35173"],"award-info":[{"award-number":["A3-S-35173"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pulmonary dysfunction is an underestimated complication in tuberculosis (TB) infection, affecting quality of life (QoL). Although respiratory function tests objectively reflect lung disturbances in a specific moment, predictors of illness severity at the time of diagnosis are still lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We measured serum pro-inflammatory cytokines (TNF-\u03b1 and IL-8), eicosanoids (PGE2, LTB4, RvD1, Mar1, and LXA4), a marker of tissue damage (cell-free nucleosomes), and indicators of redox status (malonaldehyde, 8-isoprostane, total oxidants, and antioxidants), as well as a score of radiological abnormalities (SRA) and a QoL questionnaire, in 25 patients with pulmonary TB at the time of diagnosis (t0) and two months after the initiation of treatment (t2).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found higher antioxidant levels in the patients with the worst QoL at t0, and all the indicators of the prooxidant state were significantly reduced at t2, while the total antioxidant levels increased. LTB4, a pro-inflammatory eicosanoid, was diminished at t2, while all the pro-resolutory lipids decreased substantially. Significant correlations between the SRA and the QoL scores were observed, the latter showing a substantial reduction at t2, ranking it as a reliable tool for monitoring disease evolution during TB treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These results suggest that evaluating a combination of these markers might be a valuable predictor of QoL improvement and a treatment response indicator; in particular, the oxidation metabolites and eicosanoid ratios could also be proposed as a future target for adjuvant therapies to reduce inflammation-associated lung injury in TB disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1241121","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T04:52:56Z","timestamp":1694407976000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum pro-inflammatory biomarkers associated with improvement in quality of life in pulmonary tuberculosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Laura E.","family":"Carreto-Binaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Gustavo","family":"Sartillo-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Mu\u00f1oz-Torrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Guzm\u00e1n-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Carranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"B1","unstructured":"The top 10 causes of death2020"},{"key":"B2","volume-title":"Global tuberculosis report","year":"2022"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0755","article-title":"Using the St. George Respiratory Questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis","volume":"132","author":"Pasipanodya","year":"2007","journal-title":"Chest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijid.2019.02.039","article-title":"Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis","volume":"82","author":"Vashakidze","year":"2019","journal-title":"Int J Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0551","article-title":"Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis","volume":"23","author":"Gupte","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/23120541.00083-2020","article-title":"Impact of adjuvant therapeutic surgery on the health-related quality of life of pulmonary tuberculosis patients","volume":"6","author":"Benito","year":"2020","journal-title":"ERJ Open Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11307-018-1215-x","article-title":"Computed tomography-based biomarker for longitudinal assessment of disease burden in pulmonary tuberculosis","volume":"21","author":"Gordaliza","year":"2019","journal-title":"Mol Imaging Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-75513-8","article-title":"Integration of metabolomics and transcriptomics reveals novel biomarkers in the blood for tuberculosis diagnosis in children","volume":"10","author":"Dutta","year":"2020","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tube.2012.03.006","article-title":"Chronobiology: relevance for tuberculosis","volume":"92","author":"Santos","year":"2012","journal-title":"Tuberculosis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1101\/2022.08.23.22279140","article-title":"Tuberculosis severity associates with variants and eQTLs related to vascular biology and infection-induced inflammation","volume":"19","author":"McHenry","year":"2022","journal-title":"PLoS Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0497-6_6","article-title":"Oxidative stress in tuberculosis","author":"Verma","year":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1186\/1471-2334-12-S1-P66","article-title":"Oxidative stress index as a novel biochemical marker in tuberculosis; with therapeutic benefit of antioxidant supplementation","volume":"12","author":"Kondaveeti","year":"2012","journal-title":"BMC Infect Dis"},{"key":"B14","article-title":"Immunological correlation of oxidative stress markers in tuberculosis patients","volume":"1","author":"Suresh","year":"2010","journal-title":"Int J Biol Med Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8124","article-title":"The interplay between systemic inflammation, oxidative stress, and tissue remodeling in tuberculosis","volume":"34","author":"Amaral","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0192664","article-title":"Identification of plasma biomarkers for discrimination between tuberculosis infection\/disease and pulmonary non tuberculosis disease","volume":"13","author":"La Manna","year":"2018","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.16.0176","article-title":"Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis","volume":"21","author":"Kamakia","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1086\/592448","article-title":"Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1\u03b1, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-\u03b2, TIM1, and TLR2 but low antigen-specific cellular responses","volume":"198","author":"Qiu","year":"2008","journal-title":"J Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01859-21","article-title":"Biomarkers that correlate with active pulmonary tuberculosis treatment response: a systematic review and meta-analysis","volume":"60","author":"Zimmer","year":"2022","journal-title":"J Clin Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061002","article-title":"Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment","volume":"8","author":"De Groote","year":"2013","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1904","article-title":"Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis","volume":"11","author":"Divangahi","year":"2010","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00335","article-title":"Plasma eicosanoid levels in tuberculosis and tuberculosis-diabetes co-morbidity are associated with lung pathology and bacterial burden","volume":"9","author":"Pavan Kumar","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis611","article-title":"Eicosanoids, prostaglandins, and the progression of tuberculosis","volume":"206","author":"Kaushal","year":"2012","journal-title":"J Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0078926","article-title":"A novel scoring system to measure radiographic abnorMalities and related spirometric values in cured pulmonary tuberculosis","volume":"8","author":"B\u00e1ez-Salda\u00f1a","year":"2013","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/antiox10101572","article-title":"Oxidative stress and inflammatory mediators in exhaled breath condensate of patients with pulmonary tuberculosis. A pilot study with a biomarker perspective","volume":"10","author":"Guzm\u00e1n-Beltr\u00e1n","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.05.029","article-title":"A scoring application for the St. George\u2019s respiratory questionnaire","volume":"150","author":"Gelpi","year":"2016","journal-title":"Chest"},{"key":"B27","first-page":"85","article-title":"Reproducibilidad del cuestionario respiratorio Saint George en la versi\u00f3n al espa\u00f1ol, en pacientes mexicanos con enfermedad pulmonar obstructiva cr\u00f3nica","volume":"13","author":"Aguilar-Estrada","year":"2000","journal-title":"Rev Inst Nal Enf Resp Mex"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-411OC","article-title":"Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts","volume":"173","author":"Carranza","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/dth.14460","article-title":"Aberrant expression of cell-free nucleosomes in dermatomyositis\/polymyositis","volume":"33","author":"Zhong","year":"2020","journal-title":"Dermatol Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.579849","article-title":"Elevated levels of anti-inflammatory eicosanoids and monocyte heterogeneity in mycobacterium tuberculosis infection and disease","volume":"11","author":"Nore","year":"2020","journal-title":"Front Immunol"},{"key":"B31","article-title":"Correlaci\u00f3n entre la caminata Shuttle y el cuestionario de St. George\u2019s en pacientes con enfermedad pulmonar cr\u00f3nica","volume":"18","author":"L\u00f3pez-Vargas","year":"2005","journal-title":"Rev Inst Nal Enf Resp Mex"},{"key":"B32","article-title":"Diferencias en calidad de vida de pacientes hospitalizados con EPOC y asma","volume":"19","author":"Aguilar Estrada","year":"2006","journal-title":"Rev Inst Nal Enf Resp Mex"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.022","article-title":"Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease","volume":"141","author":"Dicker","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12800","article-title":"Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis","volume":"40","author":"Lee","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026254","article-title":"Evidence for oxidative stress and defective antioxidant response in Guinea pigs with tuberculosis","volume":"6","author":"Palanisamy","year":"2011","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.13","article-title":"Role of innate cytokines in mycobacterial infection","volume":"4","author":"Cooper","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2015.08.005","article-title":"TB meets COPD: An emerging global co-morbidity in human lung disease","volume":"95","author":"O\u2019Toole","year":"2015","journal-title":"Tuberculosis (Edinb)."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.6.1988","article-title":"The effect of pulmonary rehabilitation in patients with post-tuberculosis lung disorder","volume":"123","author":"Ando","year":"2003","journal-title":"Chest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2022.100343","article-title":"Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries","volume":"29","author":"Abbas","year":"2022","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00919","article-title":"Association between health-related quality of life and medication adherence in pulmonary tuberculosis in South Africa","volume":"8","author":"Kastien-Hilka","year":"2017","journal-title":"Front Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytox.2020.100028","article-title":"Value of serum cytokine biomarkers TNF-\u03b1, IL-4, sIL-2R and IFN-\u03b3 for use in monitoring bacterial load and anti-tuberculosis treatment progress","volume":"2","author":"Nie","year":"2020","journal-title":"Cytokine X"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.201608","article-title":"Role of neutrophil extracellular traps in asthma and chronic obstructive pulmonary disease","volume":"130","author":"Liu","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00047","article-title":"NETopethic inflammation in chronic obstructive pulmonary disease and severe asthma","volume":"10","author":"Uddin","year":"2019","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0080302","article-title":"High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: Under-recognized phenomena","volume":"8","author":"Ralph","year":"2013","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1183\/1393003.congress-2017.PA2720","article-title":"Factors associated with sputum culture conversion in patients with pulmonary tuberculosis","volume":"53","author":"Musteikien\u0117","year":"2017","journal-title":"Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1241121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T04:53:02Z","timestamp":1694407982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1241121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2023.1241121"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1241121","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"article-number":"1241121"}}